Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Manipal Health Enterprises Limited (NSE: MANIPALHOS), ISIN INE459N01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MANIPALHOS last traded at ₹760.40 (+1.99%), with a 52-week range of ₹626.00 to ₹813.70 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 72.08%, FIIs 3.65%, DIIs 5.46%, mutual funds 3.53%.
EquiSense Score (ECS): 76/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.